The Food and Drug Administration on Monday granted accelerated approval to Pfizer’s Elrexfio for people with advanced multiple myeloma, making it the third drug of its type to treat the blood cancer.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,